Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (409)	2/14/2002 12:49:23 AM
From: quidditch	Read Replies (1) \| Respond to of 724

sshhhhhh! As in, don't scream it to the herd, yet. sshhhhhh! As in, shhheeesh. I did say "if" it pulls back. sshhhhhh! As in, sh_t, why didn't I buy more? quid PS And here I thought you'd recommend me to write the company's PR.

To: scaram(o)uche who wrote (409)	2/14/2002 10:36:26 AM
From: richardred	Respond to of 724

Well Richard: looks like there finally some activity on this board with good reason. I expect daily average volumes will stay more constant now. With the pick up in both technicals, and fundamentals both kicking in. This stock IMO-will start showing up into investor radar screens in small cap. opportunities. Heck, it should even get a coverage by someone now, I would think. Tuck: if your out there, thanks for putting this one on my radar screen for the recession portfolio. It gave me a good chance so I could do my homework on it, and find Richards Subject Board witch was kind of stagnant awhile back. RR

To: scaram(o)uche who wrote (409)	2/16/2002 2:29:40 PM
From: JOEBT1	Read Replies (2) \| Respond to of 724

Richard--I agree with you, with 1$/per share earnings in sight this year and an IPO of DGI in a year or two the stock could be a big winner. I've been building a position for about a year thanks to your leadership. What happened to Peter Suzman?--It seems all his posts have been deleted as well as his profile. I'm enamored of CTIC (yes I know Rosenwald is a persistent seller) with an approved drug, Trisenox, and PG-Taxol, PG-Campothecin in PI and PII trials. PG-Taxol is in 8 PI/II trials. According to CTIC PG-Taxol is 5 to 10 times more effective than Taxol with very low side effects. They are doing both combo and single drug trials. Trials include ovarian, breast, colon and nslc cancers. Preliminary results with refractory patients exciting--for ovarian patients, 8 out of 16 responses, 4 PR and 4 stable. Other positive preliminary results also. Presenting 5 reports at ASCO on PI/II trials. If you have an opinion on CTIC, I'd be very much interested. Joe